首页 | 本学科首页   官方微博 | 高级检索  
     


Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis
Authors:Yildiz Oner-Iyidogan  Pernur Oner  Hikmet Kocak  Figen Gurdol  Seldag Bekpinar  Yesim Unlucerci  Yasar Caliskan  Pinar Cetinalp-Demircan  Taner Kocak  Aydin Turkmen
Affiliation:(1) Medical Laboratory Programme, Medical Services Training School, Istanbul University, Cerrahpasa, Istanbul, Turkey;(2) Department of Biochemistry, Istanbul Faculty of Medicine, Istanbul University, Capa, 34093 Istanbul, Turkey;(3) Department of Nephrology, Istanbul University, Capa, 34093, Istanbul, Turkey;(4) Department of Urology, Istanbul University, Capa, 34093, Istanbul, Turkey
Abstract:The aim of this study was to investigate the pro-oxidant and proinflammatory biomarkers and their relationship with dimethylarginines (DMAs) in patients at various stages of chronic kidney disease (CKD). We studied 114 CKD patients, 36 were hemodialyzed, 41 peritoneal dialyzed and 37 nondialyzed (early stage) CKD patients. The control group consisted of 31 healthy subjects. Plasma levels of asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), l-arginine, nitric oxide (NO) and proinflammatory cytokines (TNF-alpha and IL-6) were determined, and their relationships with the degree of disease were evaluated. Both DMAs were at high levels in all CKD patients, whereas arginine concentrations were low in patients undergoing dialysis. Elevated TNF-α and IL-6 in CKD patients were indicative of ongoing chronic inflammatory state. A significant positive correlation between SDMA and creatinine suggests that plasma SDMA level may be an index for renal function.
Keywords:ADMA  SDMA  Chronic kidney disease  Inflammation  Dimethylarginines  Dialysis
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号